Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Years of Potential Life Lost Due to Breast and Cervical Cancer: a Challenge for Brazilian Public Policy

  • Published : 2015.01.06
Download PDF
⟨ Previous Next ⟩

Abstract

Background: The purpose of the article was to analyze the years of potential life lost (YPLL) of women who died from breast and cervical cancer in the State of Paran$\acute{a}$, Southern Brazil. This was a temporal trend study (2000 to 2010) about the coefficients of mortality and the years of potential life lost in women aged 20 to 70 years. Materials and Methods: Data were obtained through the database of the Department of the Unified Health System (DATASUS) and the National Mortality Information System. Results: There was a loss of 125.075 YPLL due to breast cancer, with an average of 11.370 YPLL. Regarding cervical cancer, the figure obtained was 91.625 YPLL from 2000 to 2010, with an average of 8.329 YPLL. Increased risk of death from breast cancer was observed for women aged 50 to 59 years, with a significant increase among those in the age group from 40 to 49 years. There was an increased rate of cervical cancer among women 40 to 69 years. Conclusions: The risk of death grows with increasing age, being higher from 40 years. Prevention is paramount for both cancers. Thus, preventive measures are required and a reassessment of political strategies should be adopted.

Keywords

References

  1. American Cancer Society (2012). Breast cancer facts & figures 2011 e 2012, Atlanta: American Cancer Society.
  2. Arnold MW, Silva MA, Falbo Neto GH, Haimenis RP (2007). Anos potenciais de vida perdidos por mulheres em idade fertil na cidade do Recife, Pernambuco, vitimas de morte por homicidio nos anos de 2001 e 2002. Rev Bras de Saude Mater Infant, 7, 23-28.
  3. Arzuaga-Salazar MA, Souza ML, Martins HEL, et al (2011). Cancer de colo do utero: mortalidade em santa catarina-Brasil, 2000 a 2009. Texto & Contexto Enfermagem, 20, 541-6.
  4. Barros AF, Uemura AG, Macedo JLS (2012). Atraso no diagnostico e tratamento do cancer de mama e estrategias para a sua reducao. Femina, 40, 32-36.
  5. Borghesan DH, Pelloso SM, Carvalho MDB (2008). Cancer de mama e fatores associados. Cienc Cuid Saude, 7, 62-68.
  6. Bouzid N, Lahmar R, Tebra S, Bouaouina N (2013). Cancer Du sein chez la femme jeune de moins de 35 ans en Tunisie: etude retrospective a propos de 124 cas. Gynecol Obstet Fertil, 41, 356-60. https://doi.org/10.1016/j.gyobfe.2013.05.002
  7. Brasil (1998). Ministerio da Saude. Investigacao sobre perfis de saude. Brasilia, DF.
  8. Brasil (2004). Instituto Nacional de Cancer, Controle do cancer de mama: documento de consenso. Rio de Janeiro: INCA.
  9. Brasil (2010). IBGE (Instituto Brasileiro de Geografia e Estatistica). Resultados da amostra do censo demografico.
  10. Brasil (2011). Ministerio da saude. Instituto nacional do cancer (INCA), Estimativa de incidencia do cancer no Brasil. Rio de Janeiro.
  11. Brasil (2012a). Ministerio da saude. Portal da saude. Incidencia do cancer no Brasil.
  12. Brasil (2012b). Instituto nacional do Cancer, Direitos sociais da pessoa com cancer/Instituto Nacional de CANCER Jose Alencar Gomes da Silva, Coordenacao Geral de acos estrategicas. Divisao de comunicacao social, 3 ed., Rio de Janeiro: INCA, Brasil.
  13. Brasil (2013a). Presidencia da Republica. Secretaria de politicas para as mulheres, plano nacional de politicas para as mulheres. Brasilia: secretaria de politicas para as mulheres, 114 p.
  14. Brasil (2013b). Datasus. Ministerio da Saude, Departamento de Informatica do SUS, Informacos de Saude. Available at: http://tabnet.datasus.gov.br/cgi/tabcgi.exe?ibge/cnv/poppr.def. Acessed: 14.04.13.
  15. Brasil (2014). Instituto nacional de cancer jose alencar gomes da silva, coordenacao de prevencao e vigilancia estimativa 2014: incidencia de cancer no Brasil/Instituto nacional de cancer jose alencar gomes da silva, coordenacao de prevencao e vigilancia. rio de janeiro: INCA, Brasil.
  16. Brischiliari SCR, Dell'Agnolo CM, Gil LM, et al (2012). Papanicolaou na pos-menopausa: fatores associados a sua nao realizacao. Cad Saude Publica, 28, 1976-84. https://doi.org/10.1590/S0102-311X2012001000015
  17. Cheung MR (2013). Assessing the impact of socio-economic variables on breast cancer treatment outcome disparity. Asian Pac J Cancer Prev, 14, 7133-36. https://doi.org/10.7314/APJCP.2013.14.12.7133
  18. Diogenes MAR, Cesarino MCF, Jorge RJB, Queiroz INB, Mendes RS (2012). Fatores de risco para cancer cervical e adesao ao exame papanicolaou entre trabalhadoras de enfermagem. Rev Rene, 13, 200-210.
  19. Dsouza DRN, Murthy NS, Aras RY (2013). Projection of cancer incident cases for India -Till 2026. Asian Pac J Cancer Prev, 14, 4387-92. https://doi.org/10.7314/APJCP.2013.14.7.4387
  20. Frie KG, Ramadas K, Anju G, et al (2013). Determinants of participation in a breast cancer screening trial in Trivandrum district, India. Asian Pac J Cancer Prev, 7301-07.
  21. Hayes DF (2007). Clinical practice, Follow-up of patients with early breast cancer. N Engl J Med, 356, 2505-13. https://doi.org/10.1056/NEJMcp067260
  22. Johnson R, Chien, F, Bleyer A (2013). Incidence of breast cancer with distant involvement among women in the United States, 1976 to 2009. JAMA, 309, 800-5. https://doi.org/10.1001/jama.2013.776
  23. Leao CR, Texeira UF, Lima EKP, et al (2012). Tendencia da Mortalidade por Cancer de Mama Feminina no Estado da Bahia, Brasil, de 1980 a 2007. RBSP, 36, 299-312.
  24. Liu PH, Wang JD, Keating NL (2013). Expected years of life lost for six potentially preventable cancers in the United States. Prev Medicine, 56, 309-313. https://doi.org/10.1016/j.ypmed.2013.02.003
  25. Martins LFL, Valente JG, Thuler LCS (2009). Factors related to inadequate cervical cancer screening in two Brasilian State Capitals. Rev Saude Publica, 43, 318-325. https://doi.org/10.1590/S0034-89102009000200013
  26. Meira KC, Gama SGN, Silva CMFP (2011). Perfil da mortalidade por cancer do colo do utero no municipio do Rio de Janeiro no periodo de 1999-2006. Rev Bras Cancerol, 57, 7-11.
  27. Melo WA, Souza LAO, Zurita RC, Carvalho MDB (2013). Fatores associados na mortalidade por cancer de mama no noroeste Paranaense. Rev Eletronica Gest Saude, 2087-94.
  28. Mendonca VG, Lorenzato FRB, Mendonca JG, Menezes TC, Guimaraes MJ (2008). Mortalidade por cancer do colo do utero: caracteristicas sociodemograficas das mulheres residentes na cidade de Recife, Pernambuco. Rev Bras Ginecol Obstet, 30, 248-55.
  29. National Cancer Institute, Cancer Trends Progress Report -2011/2012 Update, National Cancer Institute, NIH, DHHS, Bethesda, MD (2012). Available at: http://progressreport.cancer.gov. Acessed: 11.04.13.
  30. Nilaweera R, Perera S, Paranagama N, Anushyanthan AS (2012). Knowledge and practices on breast and cervical cancer screening methods among female health care workers: A Sri Lankan experience. Asian Pac J Cancer Prev, 13, 1193-96. https://doi.org/10.7314/APJCP.2012.13.4.1193
  31. Pan American Health Organization (2008). Organizacao Mundial da Saude, $48^{\circ}C$ Conselho Diretor, 60a Sessao do Comite Regional, Washington, EUA.
  32. Pereira MSLC, Ferreira LOC, Silva GA, Lucio OS (2011). Evolucao da mortalidade e dos anos potenciais e produtivos de vida perdidos por cancer de mama em mulheres no Rio Grande do Norte, entre 1988 e 2007. Epidemiol Serv Saude, 20, 161-72. https://doi.org/10.5123/S1679-49742011000200005
  33. Rodrigues BC, Carneiro ACMO, Silva TL, et al (2012). Educacao em saude para a prevencao do cancer cervicouterino. RBEM, 36, 149-154.
  34. Romeder JM, Mcwhinnie JR (1978). The development of potential years of life lost as an indicator of premature mortality. Revue d Epidemiologie et de Sante Publique, 26, 97-115.
  35. Romeiro-Lopes TC, Dell'Agnolo CM, Rocha-Brischiliari SC, et al (2013). Population inquiry regarding mammography in postmenopausal women in southern Brazil. Asian Pac J Cancer Prev, 14, 6839-44. https://doi.org/10.7314/APJCP.2013.14.11.6839
  36. Santana CKLSL, Rezende SRF, Manrique EJC (2013). Tendencia de mortalidade por cancer do colo do utero no estado de Goias no periodo de 1989 a 2009. Rev Bras de Cancerol, 59, 9-16.
  37. Santos SS (2013). Cancer de mama em mulheres jovens: incidencia, mortalidade e associacao com os polimorfismos dos genes NQO1, CYP17 e CYP19. (Dissertacao), 132.
  38. Schmidt MI, Duncan, BB, Silva GA, et al (2011). Menezes, Doencas cronicas nao transmissiveis no Brasil: carga e desafios atuais. Lancet, 61-74.
  39. Silva JMA, Souza, RC, Manzo BF, Souza SR, Pereira SM (2011). Fatores relacionados a nao continuidade da realizacao do exame citologico Papanicolaou. Percurso Academico, 1, 225-39.
  40. World Health Organization (2012). International Agency for Research on Cancer, Globocan 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide. Available at: http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx. Acessed: 14.05.14.
  41. Wu QJ, Vogtmann E, Zhang W, et al (2012). Cancer incidence among adolescents and young adults in urban Shanghai, 1973-2005. PLOS ONE, 7, 42607. https://doi.org/10.1371/journal.pone.0042607
  42. Zapponi ALB, Melo ECP (2010). Distribuicao da mortalidade por cancer de mama e de colo de utero segundo regiões Brasileiras. Rev Enferm UERJ, 18, 628-31.

Cited by

  1. The Rise in Mortality from Breast Cancer in Young Women: Trend Analysis in Brazil vol.12, pp.1, 2017, https://doi.org/10.1371/journal.pone.0168950
  2. Breast cancer screening in Brazil. Barriers related to the health system vol.63, pp.5, 2017, https://doi.org/10.1590/1806-9282.63.05.466